Delivery Order 75N93019D00011-75N93023F00003

Award Date 8/31/23
Potential Completion Date 8/30/24
Potential Value $193K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Liberty, IA 52317, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, has been awarded a $159,000 firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity multiple award contract. This delivery order is for JMI Laboratories to perform in vitro inhibitory effect determinations against...
Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, has been awarded a $195,700 firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' In Vitro Assessments of Antimicrobial Activity multiple award indefinite delivery/indefinite quantity contract. The delivery order is for in vitro screening for antibacterial activity against public health disease...
This federal contract award to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $236,000 firm-fixed-price delivery order is for the provision of services related to the assessment of antimicrobial activity of a compound collection against Gram-negative bacteria. This order is part of the In Vitro Assessments of...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases issued a $981,303 delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. JMI Laboratories will perform in vitro assessments of antimicrobial activity in support of NIH's mission under the two-year cost-plus-fixed-fee...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $755,736 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity multiple award indefinite delivery indefinite quantity contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. The delivery order requires JMI Laboratories to perform in vitro inhibitory effect determinations of experimental...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $570,000.00 Firm Fixed Price delivery order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for the "Determination of the In Vitro Inhibitory Effect of Experimental Antibacterial Substances Against Bacterial Pathogens." This delivery order is part of the larger "In Vitro Assessments of Antimicrobial...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $14,311 delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for TO ISSUE TASK A06 - LISTERIA MONOCYTOGENES MIC DETERMINATION. This delivery order was issued against the prime contractor's master Indefinite Delivery Indefinite Quantity contract called In Vitro Assessments of Antimicrobial Activity. Work will...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $76,000 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity multiple award indefinite delivery/indefinite quantity contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. Performance will take place in North Liberty, Iowa through June 2020 to provide in vitro assessments of...
This is a $89,187.11 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. The contract is for the evaluation of the relationship between phenotypic and molecular measures of antimicrobial resistance, and the development of a consultation report. This contract is not associated with a set-aside program. JMI Laboratories is a microbiology specialist company that provides a wide...
The Department of Health and Human Services Food and Drug Administration awarded a $148,940 firm-fixed-price purchase order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, to conduct research on elucidating antimicrobial resistance pharmacogenetic relationships for organisms and drug/drug classes of critical/serious concern. This work is intended to advance regulatory science and public health. The contract, which has a completion date of June 30,...

Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, has been awarded a $193,325 firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity multiple award contract. JMI Laboratories will determine the in vitro minimal inhibitory concentration of candidate products against a panel of Neisseria gonorrhoeae isolates to support the National Institute of Allergy and Infectious Diseases' antimicrobial resistance research efforts. Performance will take place in North Liberty, Iowa through August 2024. No set-aside designation was utilized for this award.

Generated 3/6/24, 12:05 PM